Kairos Pharma, LTD. (KAPA) stock
KAPANYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.46+0.02 (+3.79%)
Close on Nov 19, 2026Market cap $1.70MP/E –Yield –
Kairos Pharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Kairos Pharma's price to book ratio was 2.6× on Nov 11, 2026, against 15.9× a year earlier. Over the last 2 years it ranged from 2.6× to 41.6×, with a median of 13.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.6× | −10.9 |
| 2025 | Dec 31, 2025 | 13.5× | −27.5 |
| 2024 | Dec 31, 2024 | 41.0× | – |
See a number that looks wrong?